98 related articles for article (PubMed ID: 21370007)
1. Microwaves for chromogenic in situ hybridization.
Leong AS; Haffajee Z
Methods Mol Biol; 2011; 724():79-89. PubMed ID: 21370007
[TBL] [Abstract][Full Text] [Related]
2. Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: does it measure up to fluorescence in situ hybridization?
Bhargava R; Lal P; Chen B
Am J Clin Pathol; 2005 Feb; 123(2):237-43. PubMed ID: 15842048
[TBL] [Abstract][Full Text] [Related]
3. Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization.
Isola J; Tanner M; Forsyth A; Cooke TG; Watters AD; Bartlett JM
Clin Cancer Res; 2004 Jul; 10(14):4793-8. PubMed ID: 15269154
[TBL] [Abstract][Full Text] [Related]
4. Bright-field in situ hybridization for HER2 gene amplification in breast cancer using tissue microarrays: correlation between chromogenic (CISH) and automated silver-enhanced (SISH) methods with patient outcome.
Francis GD; Jones MA; Beadle GF; Stein SR
Diagn Mol Pathol; 2009 Jun; 18(2):88-95. PubMed ID: 19430296
[TBL] [Abstract][Full Text] [Related]
5. Dual-colour chromogenic in situ hybridization for testing of HER-2 oncogene amplification in archival breast tumours.
Laakso M; Tanner M; Isola J
J Pathol; 2006 Sep; 210(1):3-9. PubMed ID: 16823892
[TBL] [Abstract][Full Text] [Related]
6. Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma.
Zhao J; Wu R; Au A; Marquez A; Yu Y; Shi Z
Mod Pathol; 2002 Jun; 15(6):657-65. PubMed ID: 12065780
[TBL] [Abstract][Full Text] [Related]
7. The correlation between dual-color chromogenic in situ hybridization and fluorescence in situ hybridization in assessing HER2 gene amplification in breast cancer.
Pedersen M; Rasmussen BB
Diagn Mol Pathol; 2009 Jun; 18(2):96-102. PubMed ID: 19430295
[TBL] [Abstract][Full Text] [Related]
8. Reliability of chromogenic in situ hybridization for epidermal growth factor receptor gene copy number detection in non-small-cell lung carcinomas: a comparison with fluorescence in situ hybridization study.
Yoo SB; Lee HJ; Park JO; Choe G; Chung DH; Seo JW; Chung JH
Lung Cancer; 2010 Mar; 67(3):301-5. PubMed ID: 19505745
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of practical application of fluorescence in situ hybridization (FISH) analysis using microwave irradiation in formalin-fixed, paraffin-embedded tissue sections].
Kurosou K; Murakami S; Jinnai M; Koba H; Imai Y; Yamada T; Ueda Y; Mori Y
Rinsho Byori; 2002 Aug; 50(8):830-4. PubMed ID: 12373822
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor (EGFR) gene copy number detection in non-small-cell lung cancer; a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization.
Gallegos Ruiz MI; Floor K; Vos W; Grünberg K; Meijer GA; Rodriguez JA; Giaccone G
Histopathology; 2007 Nov; 51(5):631-7. PubMed ID: 17927584
[TBL] [Abstract][Full Text] [Related]
11. Chromogenic In Situ Hybridization (CISH) as a Method for Detection of C-Myc Amplification in Formalin-Fixed Paraffin-Embedded Tumor Tissue: An Update.
Todorović-Raković N
Methods Mol Biol; 2021; 2318():313-320. PubMed ID: 34019299
[TBL] [Abstract][Full Text] [Related]
12. Detection of Her-2/neu oncogene in breast carcinoma by chromogenic in situ hybridization in cytologic specimens.
Lin F; Shen T; Prichard JW
Diagn Cytopathol; 2005 Dec; 33(6):376-80. PubMed ID: 16299744
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization method in isolated single nuclei extracted from paraffin-embedded hepatocellular carcinoma tissues.
Tantiwetrueangdet A; Panvichian R; Sornmayura P; Pinpradap K; Leelaudomlipi S
J Med Assoc Thai; 2007 Feb; 90(2):363-8. PubMed ID: 17375644
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of HER2 gene amplification in invasive breast cancer using a dual-color chromogenic in situ hybridization (dual CISH).
Kato N; Itoh H; Serizawa A; Hatanaka Y; Umemura S; Osamura RY
Pathol Int; 2010 Jul; 60(7):510-5. PubMed ID: 20594272
[TBL] [Abstract][Full Text] [Related]
15. Detection of c-myc amplification in formalin-fixed paraffin-embedded tumor tissue by chromogenic in situ hybridization (CISH).
Todorović-Raković N
Methods Mol Biol; 2013; 1012():249-54. PubMed ID: 24006070
[TBL] [Abstract][Full Text] [Related]
16. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
Jimenez RE; Wallis T; Tabasczka P; Visscher DW
Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
[TBL] [Abstract][Full Text] [Related]
17. Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization.
Hyytinen E; Visakorpi T; Kallioniemi A; Kallioniemi OP; Isola JJ
Cytometry; 1994 Jun; 16(2):93-9. PubMed ID: 7924686
[TBL] [Abstract][Full Text] [Related]
18. Visualization of FISH Probes by dual-color chromogenic in situ hybridization.
Hoff K; Jørgensen JT; Müller S; Røngaard E; Rasmussen O; Schønau A
Am J Clin Pathol; 2010 Feb; 133(2):205-11. PubMed ID: 20093229
[TBL] [Abstract][Full Text] [Related]
19. Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry.
Bilous M; Morey A; Armes J; Cummings M; Francis G
Pathology; 2006 Apr; 38(2):120-4. PubMed ID: 16581651
[TBL] [Abstract][Full Text] [Related]
20. HER-2 gene amplification by chromogenic in situ hybridisation (CISH) compared with fluorescence in situ hybridisation (FISH) in breast cancer-A study of two hundred cases.
Sáez A; Andreu FJ; Seguí MA; Baré ML; Fernández S; Dinarés C; Rey M
Breast; 2006 Aug; 15(4):519-27. PubMed ID: 16290155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
